ARCHIVES

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

DCPC Board approves 7 New RFAs, 2 Pas

October 21, 1994

In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program

February 11, 1994

NCI Exceeded Mandate In Study Of Legislators, Rep. Porter Says

August 11, 1995

McGivney Out at NCCN as Board Cites Management Style, Strategic Direction

January 13, 2012

In Brief: Voters Support Increase In Research Funds, Poll Finds; Baynes Heads BMT Unit In Detroit

February 28, 1997

Congresswoman Urges Increased Funding For Cancer information Service

August 11, 1989